Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis -: art. no. 19

被引:202
作者
Reuter, BK [1 ]
Zhang, XJ [1 ]
Miller, MJS [1 ]
机构
[1] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA
关键词
D O I
10.1186/1471-2407-2-19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In recent years it has become evident that nonsteroidal anti-inflammatory drugs, in particular aspirin represent a potential class of cancer chemotherapeutic agents. Despite the wealth of knowledge gained from epidemiological, clinical and animal studies, the effectiveness of aspirin to treat established gastrointestinal cancer has not been determined. The present study examines the ability of aspirin to treat established polyposis in Min/+ mice. Methods: Min/+ mice with established polyposis were treated orally once daily from 12 16 weeks of age with either drug vehicle or aspirin (25 mg/kg). Upon completion of treatment, the number, location and size of intestinal tumours was determined. Additional variables examined were the number of apoptotic cells within tumours and COX activity. Results: Administration of aspirin for 4 weeks to Min/+ mice produce no effect on tumour number compared to vehicle-treated Min/+ mice (65+/-8 vs. 63+/-9, respectively). In addition, aspirin had no effect on tumour size or location. However, aspirin treatment produced a greater than 2-fold (p<0.05) increase in the number of apoptotic positive cells within tumours and significantly decreased hepatic PGE(2) content. Conclusions: Aspirin was found to have no effect on tumour number and size when administered to Min/+ mice with established polyposis. The findings in the present study call in to question the utility of aspirin as a stand-alone treatment for established GI cancer. However, aspirin's ability to significantly promote apoptosis may render it suitable for use in combinatorial chemotherapy.
引用
收藏
页数:8
相关论文
共 48 条
[1]  
Bak AW, 1998, LIFE SCI, V62, pPL367
[2]   Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin [J].
Barnes, CJ ;
Lee, M .
GASTROENTEROLOGY, 1998, 114 (05) :873-877
[3]  
Chiu CH, 1997, CANCER RES, V57, P4267
[4]   Discordant effect of aspirin and indomethacin on intestinal tumor burden in ApcMin/+ mice [J].
Chiu, CH ;
McEntee, MF ;
Whelan, J .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2000, 62 (05) :269-275
[5]  
Chulada PC, 2000, CANCER RES, V60, P4705
[6]   The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis [J].
Chung, DC .
GASTROENTEROLOGY, 2000, 119 (03) :854-865
[7]  
DiSArio JA, 1997, GASTROENTEROLOGY, V112, pA555
[8]   The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions [J].
Dove, WF ;
Cormier, RT ;
Gould, KA ;
Halberg, RB ;
Merritt, AJ ;
Newton, MA ;
Shoemaker, AR .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1998, 353 (1370) :915-923
[9]   UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS [J].
EBERHART, CE ;
COFFEY, RJ ;
RADHIKA, A ;
GIARDIELLO, FM ;
FERRENBACH, S ;
DUBOIS, RN .
GASTROENTEROLOGY, 1994, 107 (04) :1183-1188
[10]   Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: Role in resistance to damage [J].
Ferraz, JGP ;
Sharkey, KA ;
Reuter, BK ;
Asfaha, S ;
Tigley, AW ;
Brown, ML ;
McKnight, W ;
Wallace, JL .
GASTROENTEROLOGY, 1997, 113 (01) :195-204